Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fiona Chatterjee
Observed name:
Chatterjee, Fiona
Institutions:
Koch Institute for Integrative Cancer Research At MIT,
Massachusetts Institute of Technology
Observed institutions:
Memorial Sloan Kettering Cancer Center,
Koch Institute for Integrative Cancer Research At MIT,
Massachusetts Institute of Technology,
University of California, Berkeley
ORCID:
0000-0002-2511-9353
Observed ORCID:
0000-0002-2511-9353
OpenAlex ID:
A5082653743
MHC-dressing on dendritic cells: Boosting anti-tumor immunity via unconventional tumor antigen presentation
2023
·
Fiona Chatterjee
, Stefani Spranger
·
Seminars in Immunology
·
32
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
2022
·
Tim B Fessenden
, Lauren E Stopfer
, et al.
·
Journal for ImmunoTherapy of Cancer
·
17
PDF
Communication between distinct subunit interfaces of the cohesin complex promotes its topological entrapment of DNA
2019
·
Vincent Guacci
, Fiona Chatterjee
, et al.
·
eLife
·
15
A model for Scc2p stimulation of cohesin's ATPase and its inhibition by acetylation of Smc3p
2023
·
Kevin M. Boardman
, Siheng Xiang
, et al.
·
Genes & Development
·
8
PDF
Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
2026
·
Amy J. Wisdom
, Zachary J. Rogers
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Author response: Communication between distinct subunit interfaces of the cohesin complex promotes its topological entrapment of DNA
2019
·
Vincent Guacci
, Fiona Chatterjee
, et al.
·
eLife
·
1
Immune regulatory type 2 conventional dendritic cells restrain tumor-specific T cell responses in ovarian cancer
2026
·
Chatterjee, Fiona
, Wolczanski, Grace
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
711 Vaccination route programs qualitatively distinct dendritic cell activation states that shape anti-tumor CD8 T cell fate in ICB-resistant lung cancer
2026
·
Richard Van
, Sebnem Gul
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
PD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion
2026
·
Bhandarkar, Teresa
, Mackowiak, Sebastian
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Abstract A049: CD8+ T cell decline from regression to recurrence in ovarian cancer is linked to expansion of suppressive macrophages
2026
·
Grace Wolczanski
, Emma Schuler
, et al.
·
Cancer Immunology Research
Lymph node resident memory T cells retain effector capabilities by evading lung resident memory dysfunction
2026
·
Taylor A Heim
, Zachary J Rogers
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion
2025
·
Teresa Dinter
, Sebastian Mackowiak
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
765 Imbalance between suppressive CD103 + CD11b + dendritic cells and type 1 conventional dendritic cells blunts anti-tumor T cell responses in ovarian cancer
2025
·
Fiona Chatterjee
, Vincent Butty
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
870 Tumor-resident CD103+ CD11b+dendritic cells are associated with poor anti-tumor immunity in ovarian cancer
2024
·
Fiona Chatterjee
, Vincent Butty
, et al.
·
Journal for ImmunoTherapy of Cancer
947 The activation states of tumor-resident type 2 dendritic cells impact the strength of ovarian cancer immune responses
2023
·
Fiona Chatterjee
, Vincent Butty
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
994 Investigating the ability of tumor cell-derived type I interferon to potentiate anti-ovarian cancer immune responses
2022
·
Fiona Chatterjee
, Ellen Duong
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Show more works
View as search
Works count:
16
Citation count:
74
H-index:
4
I10-index:
3
Year
Topic
Type